BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 29439711)

  • 1. Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial.
    Gurusamy K; Corrigan N; Croft J; Twiddy M; Morris S; Woodward N; Bandula S; Hochhauser D; Napp V; Pullan A; Jakowiw N; Prasad R; Damink SO; van Laarhoven CJHM; de Wilt JHW; Brown J; Davidson BR
    Trials; 2018 Feb; 19(1):105. PubMed ID: 29439711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
    Puijk RS; Ruarus AH; Vroomen LGPH; van Tilborg AAJM; Scheffer HJ; Nielsen K; de Jong MC; de Vries JJJ; Zonderhuis BM; Eker HH; Kazemier G; Verheul H; van der Meijs BB; van Dam L; Sorgedrager N; Coupé VMH; van den Tol PMP; Meijerink MR;
    BMC Cancer; 2018 Aug; 18(1):821. PubMed ID: 30111304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet Study): study protocol for a randomized controlled trial.
    Fretland ÅA; Kazaryan AM; Bjørnbeth BA; Flatmark K; Andersen MH; Tønnessen TI; Bjørnelv GM; Fagerland MW; Kristiansen R; Øyri K; Edwin B
    Trials; 2015 Mar; 16():73. PubMed ID: 25872027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave ablation with or without resection for colorectal liver metastases.
    Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
    Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial.
    Dupré A; Pérol D; Blanc E; Peyrat P; Basso V; Chen Y; Vincenot J; Kocot A; Melodelima D; Rivoire M
    Trials; 2017 Feb; 18(1):57. PubMed ID: 28166812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
    van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
    Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.
    Tanis E; Nordlinger B; Mauer M; Sorbye H; van Coevorden F; Gruenberger T; Schlag PM; Punt CJ; Ledermann J; Ruers TJ
    Eur J Cancer; 2014 Mar; 50(5):912-9. PubMed ID: 24411080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-Guided Thermal Ablation for Colorectal Liver Metastases.
    Vasiniotis Kamarinos N; Kaye EA; Sofocleous CT
    Tech Vasc Interv Radiol; 2020 Jun; 23(2):100672. PubMed ID: 32591188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
    Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J
    Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
    Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
    Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat hepatic resection for colorectal liver metastases.
    Adair RA; Young AL; Cockbain AJ; Malde D; Prasad KR; Lodge JP; Toogood GJ
    Br J Surg; 2012 Sep; 99(9):1278-83. PubMed ID: 22864889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
    Tago T; Katsumata K; Udou R; Kasahara K; Mazaki J; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Sugimoto K; Itoi T; Tsuchida A
    Anticancer Res; 2021 Nov; 41(11):5539-5547. PubMed ID: 34732424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-stage resection and microwave ablation for bilobar colorectal liver metastases.
    Philips P; Groeschl RT; Hanna EM; Swan RZ; Turaga KK; Martinie JB; Iannitti DA; Schmidt C; Gamblin TC; Martin RC
    Br J Surg; 2016 Jul; 103(8):1048-54. PubMed ID: 27191368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.